Viewing Study NCT01210768

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2026-01-24 @ 7:47 PM
Study NCT ID: NCT01210768
Status: UNKNOWN
Last Update Posted: 2021-11-23
First Post: 2010-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients
Sponsor: TTY Biopharm
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase II View
None Pegylated Liposomal Doxorubicin View
None Adjuvant Chemotherapy View
None Breast Cancer View